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BACKGROUND: Maximizing extent of resection (EOR) and reducing residual tumor
volume (RTV) while preserving neurological functions is the main goal in the surgical
treatment of gliomas. Navigated intraoperative ultrasound (N-ioUS) combining the advan-
tages of ultrasound and conventional neuronavigation (NN) allows for overcoming the
limitations of the latter.
OBJECTIVE: To evaluate the impact of real-time NN combining ioUS and preoperative
magnetic resonance imaging (MRI) on maximizing EOR in glioma surgery compared to
standard NN.
METHODS: We retrospectively revieweda series of 60 cases operatedon for supratentorial
gliomas: 31 operated under the guidance of N-ioUS and 29 resectedwith standardNN. Age,
location of the tumor, pre- and postoperative Karnofsky Performance Status (KPS), EOR,
RTV, and, if any, postoperative complications were evaluated.
RESULTS: The rate of gross total resection (GTR) in NN groupwas 44.8% vs 61.2% in N-ioUS
group. The rate of RTV > 1 cm3 for glioblastomas was significantly lower for the N-ioUS
group (P < .01). In 13/31 (42%), RTV was detected at the end of surgery with N-ioUS. In 8
of 13 cases, (25.8% of the cohort) surgeons continued with the operation until complete
resection. Specificitywas greater inN-ioUS (42%vs 31%) andnegative predictive value (73%
vs 54%). At discharge, the difference between pre- and postoperative KPSwas significantly
higher for the N-ioUS (P < .01).
CONCLUSION: The use of an N-ioUS-based real-time has been beneficial for resection
in noneloquent high-grade glioma in terms of both EOR and neurological outcome,
compared to standard NN. N-ioUS has proven usefulness in detecting RTV> 1 cm3.
KEY WORDS: Extent of resection, Patient outcome, Gliomas, High-grade gliomas, Intraoperative ultrasound,
Neuronavigation, Residual tumor volume
Operative Neurosurgery 0:1–11, 2019 DOI: 10.1093/ons/opz203
T he goal of the surgical treatment ofcerebral high-grade gliomas (HGG)is maximizing the extent of resection
(EOR) while preserving the functionality of
relevant structures in order to ensure a good
ABBREVIATIONS: EOR, extent of resection; GBM,
glioblastomamultiforme;GTR, gross total resection;
HGG, high-grade glioma; iMRI, intraoperative MRI;
KPS, Karnofsky Performance Status; LGG, low-grade
glioma; MPrage, magnetization-prepared rapid
gradient-echo; MRI, magnetic resonance imaging;
NN, neuronavigation; N-ioUS, navigated intraoper-
ative ultrasound; RTV, residual tumor volume; US,
ultrasound;WHO,World Health Organization
neurological outcome for the patient.1-9
Increasing evidence suggests that maximizing
the EOR and minimizing the residual tumor
volume (RTV) are associated with improved
patient outcome.3,6,7,10,11
In order to improve EOR and rates of
complete resection, intraoperative image gui-
dance plays a critical role, comprising several
techniques such as neuronavigation (NN)
imaging, intraoperative ultrasound (ioUS), or
intraoperative magnetic resonance imaging
(iMRI), as well as fluorescence techni-
ques.2,8,12-23
ioUS shows some paramount advantages
over other techniques, such as low cost, fast
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reproducibility during the same intervention to obtain real-
time scans of the operative field, portability, and ease of use.
In addition, ioUS offers the possibility to be combined with
“advanced ultrasound techniques,” such as contrast-enhanced
ultrasound (US), navigated 3D US, and fusion imaging.24-31
ioUS has been reported to allow obtaining a gross total resection
(GTR) in the majority of patients.32 Major pitfalls of ioUS
technique include the lack spatial resolution, width and orien-
tation of the field of view, and scan quality, all of which are strictly
operator dependent.27 Thanks to fusion imaging, ioUS can be
aligned with preoperative MRI for intraoperative NN, allowing
to overcome the individual limitations of simple US and classical
NN. Navigated ioUS (N-ioUS) has been already validated
for abdominal applications and recently successfully applied to
neurosurgery.27,28,33,34 Despite these promising reports, only a
few studies to date aimed at evaluating the impact of N-ioUS on
cerebral glioma EOR.35
The purpose of our work is understanding howN-ioUS-guided
surgery can impact EOR, rate of complete resection, and early
neurological outcome at discharge in a series of patients with
supratentorial HGG.
METHODS
Patient Population
We retrospectively evaluated the data of a series of 60 patients, who
underwent supratentorial HGG surgical resection (Table 1). A total of
31 of those patients were operated under the assistance of a real-time
NN system based on fusion imaging of intraoperative US and preoper-
ative MRI (N-ioUS), at the Department of Neurosurgery, of Fondazione
IRCCS Istituto Neurologico “C. Besta”, Milan, Italy. A total of 29
patients were, instead, operated with the assistance of a standard NN,
at the Department of Neurosurgery of Geneva University Hospitals,
Geneva, Switzerland. On both sites, surgeries were performed, between
October 2010 and December 2014, by board-certified neurosurgeons
with at least 5 yr of surgical experience. The institutional review board
provided approval for this study, all patients were thoroughly informed
about the surgical procedure, and written consent was obtained.
The 2 groups were compared in parallel. Pre- and postoper-
ative Karnofsky Performance Status (KPS), pre- and postoperative
tumor volume, EOR, and postoperative complications were evaluated.
(Continued from previous page)
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TABLE 1. Preoperative Overall Patients’Data
Overall
N 60
Age (mean [SD]) 55.32 (14.84)
Gender
Male (%) 38 (63.3)
Female (%) 22 (36.7)
Gliomas
WHO III (%) 9 (15.0)
WHO grade IV (%) 51 (85.0)
N-ioUS (%) 31 (51.7)
NN (%) 29 (48.3)
Localization
Noneloquent (%) 40 (66.7)
Eloquent (%) 20 (33.3)
Tumor volume cm3 (mean [SD]) 36.69 (31.16)
Preoperative KPS (median [IQR]) 80.00 [77.50, 90.00]
The 2 groups were comparable considering the variables investi-
gated (Table 2). All patients performed a preoperative T1 gadolinium
magnetization-prepared rapid gradient-echo (MPrage) MRI sequence
(Siemens, Munich, Germany) for surgical planning and postoperative
MRI evaluation of EOR, as explained below. Patients were subgrouped
according to tumor location: all patients with tumors in eloquent
areas (primary motor cortex, primary visual cortex, and speech areas)
were operated on with asleep neurophysiological monitoring techniques
(motor evoked potentials, sensory evoked potentials, and cortical and
subcortical stimulation), whereas others were operated under general
anesthesia. Histological diagnosis was obtained to confirm the diagnosis
of HGG. Eloquent and noneloquent lesions were separately evaluated
(Table 1).
N-ioUS Technique Assessment
In the N-ioUS group, we used an US system (MyLab Twice, Esaote,
Genova, Italy) equipped with Fusion Imaging for Virtual Navigator
(MedCom GmbH, Darmstadt, Germany) to obtain the fusion of 2D
US images with the coplanar preoperative MRI. ioUS imaging at
Fondazione IRCCS Istituto Neurologico “C. Besta” was performed
directly by surgeons (Drs Prada and DiMeco) with expertise and training
in US. Preoperative images were acquired by 3T MRI volumetric, T1-
weighted, gadolinium contrast-enhanced, and fluid attenuated inversion
recovery sequences. The US is equipped with an electromagnetic virtual
navigation system for instrument tracking. The probe used is a linear
transducer with variable band with a bandwidth of 3 to 11 MHz
(Esaote LA332, Genova, Italy), protected with a sterile cover (CIVCO,
Coralville, Iowa) for the implementation of ioUS scan. The technique of
ioUS and preoperative MRI fusion was performed as a rigid registration
of external bony landmarks with a pointer. The reference for electromag-
netic navigation was then placed on the US probe in order to continue
the navigation in pair with US images. This technique allows to plan a
craniotomy based on preoperative MRI images as every NN tools. Once
the bone flap is removed, a first US control is made, before opening the
dura, to check the accuracy. This also allows for correction of the brain
shift according to intracranial landmarks, in order to realign US andMRI
(fine-tuning) and to restart the navigation process with coplanar images.
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TABLE 2. Comparison between NN and N-ioUS Groups
NN N-ioUS p Test
n 29 31
Age (mean [SD]) 56.31 (15.41) 54.39 (14.48) 0.62 Student t
Gender
Male (%) 19 (65.5) 19 (61.3) 0.793 Exact
Female (%) 10 (34.5) 12 (38.7) (Fisher)
Gliomas
WHO III (%) 2 (7.0) 7 (22.6) 0.2731 Exact
WHO IV (%) 27 (93.0) 24 (77.4) (Fisher)
Localization
Noneloquent (%) 20 (69.0) 20 (64.5) 0.788 Exact
Eloquent (%) 9 (31.0) 11 (35.5) (Fisher)
Tumor volume cm3 (mean [SD]) 36.21 (29.64) 37.14 (33.00) 0.909 Student t
Preoperative KPS (median [IQR]) 80.00 [80.00, 90.00] 80.00 [65.00, 90.00] 0.281 Nonnorm (Wilcox)
FIGURE 1. B-mode ioUS scan performed after the removal of the bone flap in a case of left temporal GBM. Ultrasound (left)
fused in “overlapping mode” with a contrast-enhanced, T1-weighted preoperative MRI (right). In both images aside from the
lesion, perilesional edema and adjacent cerebral structures, such as the lateral ventricles, thalamus, head of the caudate nucleus,
and lenticular, nucleus can be seen.
A more extensive description of this technique is reported in published
work.27,28,33
In all cases, a craniotomy was performed under the guidance of
virtual navigation system. After bone flap removal, a first control was
performed with N-ioUS on closed dura, to correctly identify the lesion
and surrounding structures (Figure 1). Any misalignment of the images
was reported and corrected with fine-tuning operation (Figure 2), a tool
allowing to freeze both US or MRI images and to realign them, to restart
navigation with a restored accuracy. This maneuver can be repeated
several times during surgery (every time that the surgeon detects a loss of
accuracy), and a multiplanar correction can also be performed. Thanks
to these operations, the surgeon is able to reduce brain-shift effects on
navigation, as previously described.27,28 The identification of potential
residual tumor, respective to the apparently complete resection, was
reported by the operators in their records for every patient included in
the study. In case the N-ioUS detected residual tumor tissue on navigated
B-mode images, this was considered as a true residual and surgery was
completed or stopped according to the ioUS findings, depending on the
eloquent or noneloquent tumor location and according to the surgeon’s
judgment.
NN Control Group
All patients in the NN group were operated on with the guidance
of standard NN (Brainlab, Munich, Germany). All craniotomies were
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FIGURE 2. Rolandic glioblastoma shown in B-mode ioUS scan a clear fusion mismatch before (upward) corrected
after (below) fine-tuning. Image matching is performed with anatomical landmarks as reference.
planned and tailored to the lesion according to NN. At the end of the
intradural part of the intervention NN, we used to perform a last control
of resection margins and check their accordance to preoperative MRI.
EOR and Outcome
The EORwas calculated by comparingMRI studies performed before
surgery with early postoperative MRI studies (within 48 h). T1 MPrage
contrast-enhancing volume was manually segmented on each section of
MRI studies using a dedicated software (Iplannet, Brainlab, Munich,
Germany). As previously described, the EOR was calculated using the
following formula:
[(Preoperative Volume - Postoperative Volume) / Preoperative Volume]
x 100.11
GTR was considered as EOR = 100%. Thus, we divided the patients
into 3 groups according to the degree of resection: GTR, EOR ≥ 90%,
and EOR < 90%. The assessment of tumor volumes was performed by
A.M. (fourth year resident in neurosurgery) and validated by F.P. (board
certified neurosurgeon). Data on patients’ outcomes were collected from
neurosurgeons’ medical records at the time of presentation and discharge
letters, with particular care for new onset neurological deficits and differ-
ences between post- and preoperative KPS (KPS).8,11
Statistical Analysis
Data are represented as mean + SEM, unless otherwise specified.
The statistical analysis was performed with the Mann-Whitney U-test
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FIGURE 3. Extent of tumor resection (EOR) for the NN and N-ioUS groups, considering the entire HGG
cohort. EOR in the NN and N-ioUS groups, considering just the tumors diagnosed as GBM. ∗P < .05.
and Fisher’s exact test. Statistical analysis was performed using GraphPad
Prism 6 (GraphPad Software, San Diego, California).
RESULTS
A total of 60 patients were included (22 females and 38 males,
with a mean age of 55 yr, range 18-77) with a mean preoperative
KPS of 80 (median 80, range 40-100). The sample includes a total
of 9 World Health Organization (WHO) grade III and 51WHO
grade IV (39 primary diagnosed glioblastoma multiforme [GBM]
and 12 recurrent GBM). The detailed clinical characteristics of
the cohort are summarized in (Table 1).
Craniotomy Planning
In all cases, the craniotomy was correctly positioned, showing
no differences between the 2 groups. In all 31 cases studied
with N-ioUS, fine-tuning was performed immediately after the
removal of bone and/or during resection, in order to correct
the displacement between the images caused by brain shift. No
complications in the operative field have been reported in both
groups.
EOR and RTV
The 2 patient groups (NN and N-ioUS) were comparable
for age, sex, tumor localization (eloquent or noneloquent),
preoperative tumor volume, and preoperative clinical presen-
tation (Table 2).
We obtained an EOR average of 96% in the NN group and
97% in the N-ioUS group with no statistical significance for
HGG, but significance for GBM (P< .04) (Figure 3). The rate of
GTR in the NN group was 44.8%, and EOR< 90% was 10.3%,
whereas in the N-ioUS group a 61.2% GTR rate was obtained
with a 6.4% rate of EOR < 90% (Figure 4). Considering only
GBM, we found 44.4% rate of GTR in the NN group and 66.6%
in the N-ioUS group, and 11.1% of EOR < 90% in the NN
group compared with 4.1% in the N-ioUS group (Figure 4).
A postsurgical RTV is one of the most important predictors of
poor patient outcome in GBM.7,11 In order investigate the role
of N-ioUS in minimizing the RTV, we compared this value in
the 2 cohorts. The rate of RTV > 1 cm3 for GBMs was signifi-
cantly lower for the N-ioUS group (P < .01, Figure 5) compared
to the NN group. In order to better understand the impact
of N-ioUS on GBM surgery, we performed the same analysis
just for lesions affecting eloquent areas, operated under the
guidance of functional mapping techniques with the assistance
of imaging techniques like N-ioUS an NN. As a comparison, we
also performed the same analysis for lesions in noneloquent areas,
in which the resection was only guided by N-ioUS or NN. This
analysis revealed that the N-ioUS group had a significant lower
rate of postoperative RTV > 1 cm3 (P < .02), but this was not
significant for eloquent lesions (P < .1, Figure 5). Furthermore,
we registered one case of noneloquent GBM in the NN group,
for which the postoperative MRI showed a 2.85 cm3 RTV, so that
the patient had to undergo a second surgery to achieve complete
resection. No cases for which a second surgery was required were
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FIGURE 4. Representation for level of EOR considering GTR as EOR = 100% of contrast-enhancing lesion: for the NN and N-ioUS groups,
considering the GBM cohort, in the NN and N-ioUS groups, considering GBMs situated in eloquent areas, and in the NN and N-ioUS groups
considering GBMs located in noneloquent areas.
FIGURE 5. Rate of postoperative RTV > 1 cm3 and RTV < 1 cm3: for the NN and N-ioUS groups, considering the GBM cohort, in the NN and N-ioUS
groups, considering GBMs situated in eloquent areas and in the NN, and N-ioUS groups considering GBMs located in noneloquent areas. ∗P < .05.
registered in the N-ioUS group. Collectively, these data indicate
that N-ioUS, compared to NN alone, could be particularly useful
in minimizing the RTV in noneloquent GBMs
Complications and Outcome
Intraoperative complications were observed in none of the 2
groups. For 5 cases (16%) in the N-ioUS group, we observed
additional neurological deficits in the immediate postoperative
period, and 3 patients showed transient minor deficits, with
a rapid improvement of symptoms within a few postoperative
days and a complete recovery at discharge. In 2 cases, postop-
erative complications occurred, but were likely not related to
the use of US technique: one case of rigor nucalis and hyper-
pyrexia with negative blood and urine cultures, which resolved
after treatment with intravenous vancomycin and ceftriaxone,
and one case of hematemesis likely due to steroid therapy. In
the NN group, we registered 7 cases (24.1%) of postoperative
neurological deficits. A 75-yr-old patient had no neurological
changing after the intervention, but died of a massive pulmonary
embolism.
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FIGURE 6. Difference between pre- and postoperative outcome considering KPS: for the NN and N-ioUS groups, considering the GBM cohort,
in the NN and N-ioUS groups, considering GBMs situated in eloquent areas and in the NN and N-ioUS groups considering GBMs located in
noneloquent areas. ∗P < .05, ∗∗P < .01, ∗∗∗P < .001.
At discharge, the KPS was significantly higher for the
N-ioUS (P < .01), particularly in the noneloquent subgroup
(P < .01), a similar trend was observed in the eloquent subgroup,
but not significant (P < .1; Figure 6).
N-ioUS Findings
In 13/31 (42%), RTV was detected at the end of surgery
with N-ioUS. In 8 of 13 cases (25.8% of the cohort), surgeons
continued with the operation until complete resection was
documented with N-ioUS. In the remaining 5 cases, the
identified residual tumor could not be removed because of its
position close to eloquent structures. In all of these 5 cases, the
presence of residual tumor was confirmed by postoperative MRI,
with a postoperative average volume of 9.63 cm3 (range 2.37-
14.74 cm3).
In a group of 26 of 31 patients, apparent complete resection
was assumed from the US control. In 19 of these 26 (73%),
the postoperative MRI confirmed complete removal of the tumor
mass (Figures 7 and 8). In the remaining 7 of 26 cases (26.9%)
in which the US assessment was contradicted by the finding of
residual tumor on postoperative MRI (false negatives), the mean
residual volume was an average 0.46 cm3 (range 0.25-0.82 cm3),
obtaining a mean EOR = 98.1%, whereas in the NN subgroup,
false-negative RTV was an average 1.82 cm3 (range 0.24-6.71
cm3) with a mean EOR = 95%.
In our series, we found a greater specificity for identifying RTV
intraoperatively in the N-ioUS group (42% vs 31%). Negative
predictive value for RTV of the N-ioUS was also higher compared
to the NN group (73% vs 54%).
DISCUSSION
An increasing number of studies have reported the usefulness
of ultrasonography in identifying glial lesions and guide their
resection, with one of the first reports being presented by
Unsgaard et al,26,31,36-38 who reported 114 intracranial lesions
operated under 2D ioUS guidance between 1997 and 2001.
Resection Rates
We obtained a postoperative GTR of 61.2% in the N-
ioUS patients against the 44.8% of the NN group in a series
of 60 nonselected consecutively operated supratentorial HGG.
According to literature, several groups have reported higher EOR
using NN, opposed to surgery without NN.12,39 In a few studies,
the assessment of the EOR for gliomas operated with ioUS has
shown encouraging results, although it must be considered that
these studies are often conducted using nonvolumetric measure-
ments.40,41 Solheim et al42 have reported a 37% rate of GTR in
a series of 156 malignant gliomas consecutively operated with
3D ioUS, with a worsening of neurological functions to 4 to
6 wk in 13% of cases. In a subgroup of patients with unifocal
lesions, contrast-enhancing, noninvasive basal ganglia, thalamus,
or corpus callosum, and with KPS > 70, the percentage of cases
with GTR grows to 63%.42 In a study of Moiyadi et al43 the use
of 3D ioUS in a series of 51 HGG has led to obtain a GTR in
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FIGURE 7. B-mode ultrasound image (left) and MRI (right), pre- (top) and postresection (bottom) in a case of 87 cm3 left frontal
glioblastoma with EOR= 100% confirmed by postoperative MRI. The overlap of the surgical cavity, seen on ultrasound scan (bottom
left), and the lesion on preoperative MRI (bottom right) allows to verify the perfect correspondence between the limits of the tumor
and the margins of the cavity after surgical resection.
47% of cases, with a frequency of complications similar to those
obtained with other intraoperative imaging techniques. Dividing
the series in resectable and unresectable tumors, the fraction of
GTR increased up to 88% for resectable lesions, and was reduced
to 24% for unresectable ones.43 In a recently published study,
Štenˇo et al44 reported an increased resection rate in low-grade
glioma (LGG) resection combining 3D ioUS to awake resection
techniques, compared to a previous series of patients operated
in awake surgery and the only aid of standard NN. Despite the
limitations of our study and of the published literature, having
a real-time intraoperative reference during glioma surgery seems
beneficial for both LGG and HGG.
RTV and Outcome
Not only the EOR but also increased residual volume appears
to be an independent prognostic factor for reduced survival in
HGG.1,6-8,11 US technique seems to be more accurate than
standard NN for identifying residual tumor, with excellent sensi-
tivity for volumes greater than 2 cm3, but with reduced accuracy
for volumes smaller than 1 cm3.39,40 The better accuracy of iMRI
in detecting small residues < 1 cm3 has already been reported
in the literature.40 Consistently with these studies, we reported
an advantage in favor of N-ioUS in detecting RTV > 1 cm3
in noneloquent GBM. In a recent prospective study, Coburger
et al45 reported that modern linear high-frequency ioUS reaches
a degree of accuracy close to iMRI in detecting residual tumor
masses during intraoperative resection control in HGG. Sensi-
tivity was even higher in linear array ioUS (76%) than in iMRI
(55%) without significant differences in specificity for both.45 In
our N-ioUS cohort, in 7 of 26 cases with assumed intraoperative
complete resection, a residual tumor could be detected by postop-
erativeMRI control (average volume of 0.46 cm3). Specificity and
positive predictive value of N-ioUS were higher than NN in our
series. As ioUS helps differentiating between tumor and healthy
brain tissue, ioUS can help achieving a maximal resection while
providing safety.
In 13 of 31 cases, the N-ioUS evaluation at the end of resection
allowed to identify residual tumor, which could not be identified
by NN. For 8 of these cases, the surgery continued and resection
was completed according toN-ioUS, reaching anMRI-confirmed
GTR without additional neurological deficits for the patients.
Only 1 out of these 8 patients presented a neurological deficit
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FIGURE 8. B-mode ultrasound scans (left images) and preoperative MRI images (right images) at the end of resection in a case of
glioblastoma (above) and fibrillary astrocytoma (below). In both cases, a hyperechoic area on the bottom of the surgical cavity (black
arrows) can be observed, associated with the presence of a residual tumor mass, and confirmed later by postoperative MRI. In the
lower left image, the residue is partially hidden by the presence of back reinforcement artifacts behind the operative cavity (white
arrows), due to the presence of blood and surgical manipulation. In this case, the comparison with the preoperative images (right)
helps the operator in the interpretation of a doubtful image.
in the immediate postoperative (mixed aphasia), showing a rapid
improvement until discharge. For the remaining 5 of these 13
cases, it was not possible to go beyond the actual resection, and
the average residual volume was 9.63 cm3. N-ioUS has proven
to be safe showing, in noneloquent localization, a significantly
better postoperative KPS, compared to the NN control group.
The onset of neurological deficits in the immediate postoperative
period in our series was similar to what reported in the literature.46
Limitations
The main limitation of this work resides in its retrospective
nature. We attempted to limit the retrospective bias associated
with this approach by confirming the EOR with pre- and postop-
erative MRI, reducing selection bias and not selecting the groups
of patients based on age, tumor size and location, and preoper-
ative conditions of patients. The use of a control group from a
different institution is also a limitation of our study. However, it
would be nearly impossible, outside of a prospective clinical trial,
having 2 cohorts of patients from the same institution undergoing
2 different surgical treatments without considering different time
periods. We privileged studying a series of patients operated
during the same period with the same standards (even if it remains
a limitation), instead of considering the cases operated by the
same surgeons before starting their experience with ioUS. This
last possibility would have probably augmented the experience
bias, as well as introduced a considerable difference concerning
patients’ data quality.
Technical Considerations
N-ioUS was employed for surgical planning and craniotomy
placing, to identify the lesion before dural opening and
during tumor resection, for brain-shift correction, and for the
detection of any residual tumor at the end of surgery. For all
31 N-ioUS group cases, it was necessary to use fine-tuning during
the operation, after the removal of the operculum bone, and,
subsequently, during intradural surgery in order to correct the
discrepancies between ioUS and MRI images caused by brain
shift. In all these cases relying on US images, the surgeon was
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always able to correct navigationmisalignment. Recalibration and
fusion of US imaging and MRI has demonstrated an excellent
ability to compensate the loss of accuracy due to brain shift.28 On
the other hand, at the end of most of the surgeries, a substantial
distortion and deformation of brain parenchyma often makes
it impossible to have a precise overlap between images. In this
case, the surgeon relies exclusively on US images. In cases of
important parenchymal deformation, it would have been impos-
sible to complete any intervention relying solely on images from
the initial registration because of the increasing navigation loss
of accuracy, possibly emphasizing the drawbacks of the classical
NN.
The pursuit of a radical resection seems feasible thanks to
fluorescence-guided surgery, but obtaining more complete and
aggressive resections can augment the risks of a neurological
deterioration of the patient.16,17,47,48 The authors believe that
the use of an intraoperative imaging technique such as N-ioUS
coupled with advanced US imaging techniques such as contrast-
enhanced US and elastography49–51 will allow a well-trained
neurosurgeon to overcome the limitations of standard B-mode
imaging, fostering the understanding of different US techniques.
Ultimately, the use of ioUS in synergy with intraoperative fluores-
cence techniques might lead to higher resection rates with reduced
morbidity, and future studies are needed to clarify the exact
potential of this combination.
CONCLUSION
Despite the limitations of the study, N-ioUS has proved
beneficial for the resection of HGG located in noneloquent areas,
in terms of both EOR and postoperative neurological outcome.
In our experience, N-ioUS appears to be reliable in identifying
RTV with volumes > 1 cm3, whereas, for smaller volumes, the
accuracy of US is decreased.
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